CARsgen Therapeutics Announces HK$470 Million Top-Up Placing and Subscription to Fund Global CAR T-Cell R&D and Expansion
CARsgen Therapeutics Announces HK\$470 Million Share Placing...
Sign in to continue:
CARsgen Therapeutics Announces HK\$470 Million Share Placing...
SUTL Enterprise Limited 32nd AGM: Key Highlights and Investo...
Details for Shareholders and Investors Price-Sensitive In...
CDL and DBS Launch S\$300 Million Sustainability-Linked Loan...
China Gold International Resources Reports Record Q1 2026 Re...
SUTL Enterprise Limited Extends Long Stop Date for Marina at...
RemeGen Co., Ltd. Announces Discloseable RMB 453 Million Inv...
丽江玉龙旅游股份有限公司2025年度权益分派实施公告深度解读 丽江玉龙旅游股份有限公司2025年度权益分派实施公告深...
一、公告要点概述 公司拟回购注销2024年限制性股票激励计划部分激励对象已获授但尚未解除限售的限制性股票7,8...
山东未名生物医药股份有限公司收到参股公司分红公告解读 山东未名生物医药股份有限公司收到参股公司分红 1.35亿元 公...